VANGUARD GROUP INC - PROTAGENIC THERAPEUTICS INC ownership

PROTAGENIC THERAPEUTICS INC's ticker is PTIX and the CUSIP is 74365N103. A total of 17 filers reported holding PROTAGENIC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PROTAGENIC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$94,523
-34.8%
236,309
-6.5%
0.00%
Q3 2022$145,000
-20.8%
252,8250.0%0.00%
Q2 2022$183,000
-11.2%
252,8250.0%0.00%
Q1 2022$206,000
-41.1%
252,8250.0%0.00%
Q4 2021$350,000
+42.3%
252,825
+92.2%
0.00%
Q3 2021$246,000
+310.0%
131,515
+532.8%
0.00%
Q2 2021$60,00020,7830.00%
Other shareholders
PROTAGENIC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 75,000$61,0000.06%
ORACLE INVESTMENT MANAGEMENT INC 20,000$16,0000.00%
Virtu Financial LLC 13,045$11,0000.00%
Renaissance Technologies 102,200$83,0000.00%
ROYAL BANK OF CANADA 1$00.00%
VANGUARD GROUP INC 252,825$206,0000.00%
UBS Group AG 2,393$2,0000.00%
OSAIC HOLDINGS, INC. 5,055$4,0000.00%
BANK OF AMERICA CORP /DE/ 4$00.00%
WELLS FARGO & COMPANY/MN 85$00.00%
View complete list of PROTAGENIC THERAPEUTICS INC shareholders